Compare NTRA & FIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRA | FIS |
|---|---|---|
| Founded | 2003 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.9B | 34.0B |
| IPO Year | 2015 | N/A |
| Metric | NTRA | FIS |
|---|---|---|
| Price | $231.21 | $54.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 18 |
| Target Price | ★ $249.53 | $83.82 |
| AVG Volume (30 Days) | 1.1M | ★ 3.5M |
| Earning Date | 02-26-2026 | 02-13-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.29 |
| Revenue | $2,116,676,000.00 | ★ $10,464,000,000.00 |
| Revenue This Year | $33.77 | $5.82 |
| Revenue Next Year | $16.92 | $6.75 |
| P/E Ratio | ★ N/A | $190.58 |
| Revenue Growth | ★ 38.17 | 4.21 |
| 52 Week Low | $125.38 | $54.65 |
| 52 Week High | $256.36 | $83.97 |
| Indicator | NTRA | FIS |
|---|---|---|
| Relative Strength Index (RSI) | 44.72 | 18.65 |
| Support Level | $229.14 | $59.95 |
| Resistance Level | $250.00 | $66.73 |
| Average True Range (ATR) | 8.27 | 1.78 |
| MACD | -1.38 | -0.90 |
| Stochastic Oscillator | 21.29 | 4.26 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Fidelity National Information Services provides core processing and ancillary services to banks, but its business has expanded over time. By acquiring SunGard in 2015, the company now provides record-keeping and other services to investment firms. With the acquisition of Worldpay in 2019, FIS was providing payment processing services for merchants and holding leading positions in the United States and United Kingdom. But the company sold off a majority interest in Worldpay and now has only a minority stake.